 pharmacolog activ bepaf web new select hetrazepino antagonist platelet factor hetrazepin web intern nonproprietari name bepaf thieno-triazolodiazepin platelet factor paf antagonist web potent select paf antagonist vitro vivo web paf-induc human platelet neutrophil aggreg vitro valu microm littl inhibitori action aggreg agonist potenc vitro compar web casals-stenzel muacev weber k.h pharmacol exp ther guinea pig i.v infus paf ng oral mg/kg intraven mg/kg treatment web intrathorac accumul platelet bronchoconstrict hypotens death dose-depend fashion oral mg/kg intraven mg/kg beta agonist fenoterol steroid dexamethason properti elderli nmri mice lethal effect paf anesthet rat intraven mg/kg oral mg/kg inhibit paf-induc hypotens dose-rel manner coadministr web paf-induc increas vascular permeabl rat skin half-tim durat action rat oral administr intraven applic conclus hetrazepin web strong select paf antagonist vitro equipot contrast vivo oral web speci paramet time potent exogen paf-induc alter hetrazepin web mice rat oral web superior